Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Biotechs will need to be strategic to achieve “tariff-era success” as the sector enters an “America-first resurgence,” ...

A U.S. congressional commission has made the case for “swift action” to maintain the nation’s role as a biotech superpower, while warning the sector is “dangerously close to falling behind ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

"China's biotechnology sector thrives on a dual engine — Beijing's constellation of famous medical universities training great minds and biotechnology, coupled with an environment that's ...

Recent years have seen it become a formidable hub of biotechnology innovation, after the Chinese government gave priority to the field as a critical sector in China’s efforts to become a ...

Omnivore, one of India’s leading sustainability-focused venture capital firms, has released a report titled "India Life Sciences Startup Investing Report – A Five-Year Review" in partnership ...

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

Ottawa, April 10, 2025 (GLOBE NEWSWIRE) -- The global biotechnology market size was valued at USD 1,550.96 billion in 2024 and is predicted to hit around USD 5036.46 billion by 2034, a study ...